Pasithea Therapeutics Corp - Warrants (11/08/2026)
KTTAW
Get informed when a big investor buys or sells
+ FollowMarket Cap$17.5M
Close$
$13.25
473025% upside
Current Fair Value
473025% upsideUndervalued by 473025% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $17.50 Million |
|---|---|
| Enterprise Value | $-45,646,282,855.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.91 |
| Beta | 0.29 |
| Outstanding Shares | 7,031,000 |
Return
| Return on Equity | -63.40% |
|---|---|
| Return on Assets | -61.11% |
| Return on Invested Capital | -27.56% |
Valuation & Multiples
| P/E Ratio | -0.21 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 3.32 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
$-0.16
Average shareholder expectationRevenue Estimate
$300,000
Average shareholder expectationNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
$-0.21
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.53%▼ 0.44% |
|---|---|
| Total Invested | $3,184▼ 42.33% |
| Investors Holding | 6▲ 1.00% |
ESG Score
No data
About Pasithea Therapeutics Corp
2 employees